Hepatic arterial infusion of floxuridine has shown benefit in intrahepatic cholangiocarcinoma. Due to the complexity and expense of this treatment, a pre-treatment or early biomarker of efficacy would be advantageous. We employed non-model-based (NMB) analysis to maximize information from breath-motion degraded DCE-MRI in 24 patients. Model-based and NMB parameters were compared to RECIST response. The kurtosis value of pre-treatment time-to-half-maximum correlated with response, as did 1 month changes in perfusion parameters (Ktrans and signal at half maximum). NMB analysis resulted in fewer voxels being discarded due to motion and thus may be more representative of tumor physiology while not requiring modeling.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords